These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17699403)

  • 21. [Mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Rinsho; 2005 May; 63 Suppl 5():684-91. PubMed ID: 15954430
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic drug monitoring of mycophenolates: why make simple things complicated?
    Kuypers DR; van Gelder T
    Transplant Rev (Orlando); 2011 Apr; 25(2):45-6. PubMed ID: 21477747
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate mofetil: a decade of clinical experience.
    Danovitch GM
    Transplantation; 2005 Oct; 80(2 Suppl):S272-4. PubMed ID: 16251860
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic drug monitoring of mycophenolates in kidney transplantation: report of The Transplantation Society consensus meeting.
    Le Meur Y; Borrows R; Pescovitz MD; Budde K; Grinyo J; Bloom R; Gaston R; Walker RG; Kuypers D; van Gelder T; Kiberd B
    Transplant Rev (Orlando); 2011 Apr; 25(2):58-64. PubMed ID: 21454067
    [No Abstract]   [Full Text] [Related]  

  • 25. Mycophenolate mofetil: a promising immunosuppressive agent.
    Kulkarni AA; Shah BV
    J Assoc Physicians India; 2004 Jan; 52():33-8. PubMed ID: 15633716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
    Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
    Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation.
    Hale MD; Nicholls AJ; Bullingham RE; Hené R; Hoitsma A; Squifflet JP; Weimar W; Vanrenterghem Y; Van de Woude FJ; Verpooten GA
    Clin Pharmacol Ther; 1998 Dec; 64(6):672-83. PubMed ID: 9871432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate: better value through monitoring?
    Tredger JM; Brown NW
    Transplantation; 2006 Feb; 81(4):507-8. PubMed ID: 16495794
    [No Abstract]   [Full Text] [Related]  

  • 29. Monitoring of mycophenolic acid in clinical transplantation.
    Shaw LM; Pawinski T; Korecka M; Nawrocki A
    Ther Drug Monit; 2002 Feb; 24(1):68-73. PubMed ID: 11805725
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring of mycophenolic acid in pediatric renal transplant recipients.
    Armstrong VW; Shipkova M; Schütz E; Weber L; Tönshoff B; Oellerich M;
    Transplant Proc; 2001; 33(1-2):1040-3. PubMed ID: 11267182
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of mycophenolic acid after a single and multiple oral doses of mycophenolate mofetil in Chinese renal transplant recipients.
    Liang MZ; Lu YP; Nan F; Yu Q; Qin YP; Zou YG
    Transplant Proc; 2004 Sep; 36(7):2065-7. PubMed ID: 15518747
    [No Abstract]   [Full Text] [Related]  

  • 32. Mycophenolate mofetil.
    Lipsky JJ
    Lancet; 1996 Nov; 348(9038):1357-9. PubMed ID: 8918281
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
    J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic drug monitoring of mycophenolic acid can be used as predictor of clinical events for kidney transplant recipients treated with mycophenolate mofetil.
    Lu YP; Zhu YC; Liang MZ; Nan F; Yu Q; Wang L; Wang J; Li YP
    Transplant Proc; 2006 Sep; 38(7):2048-50. PubMed ID: 16979995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.
    Kaplan B
    Curr Med Res Opin; 2006 Dec; 22(12):2355-64. PubMed ID: 17257450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443).
    Laskow DA; Deierhoi MH; Hudson SL; Orr CL; Curtis JJ; Diethelm AG
    Transplantation; 1994 Feb; 57(4):640-3. PubMed ID: 8116055
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature.
    Arns W; Cibrik DM; Walker RG; Mourad G; Budde K; Mueller EA; Vincenti F
    Transplantation; 2006 Oct; 82(8):1004-12. PubMed ID: 17060847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic drug monitoring of mycophenolic acid in renal transplant recipients.
    Okamoto M; Wakabayashi Y; Higuchi A; Kadotani Y; Ogino S; Ushigome H; Akioka K; Kaihara S; Yoshimura N
    Transplant Proc; 2005 Mar; 37(2):859-60. PubMed ID: 15848556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil: how to further improve using an already successful drug?
    van Gelder T
    Am J Transplant; 2005 Feb; 5(2):199-200. PubMed ID: 15643976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.